Synovo is helping rheumatoid arthritis patients be seen based on how their disease is progressing rather than simply when their next appointment is due
Public source
Publisher name
Public post
NHS priorities around digitisation and outpatient reform need an effective execution layer. I am increasingly confident that Synovo can play a meaningful role in that. B…
Company
Synovo
AI-Driven Arthritis Scoring & Monitoring for the Best Outcomes
- Industry
- Technology, Information and Internet
- Location
- London, GB
- Company size
- 1 employee
About Synovo
SYNOVO combines “Synovial Fluid” vital for healthy joints and “Novo” or new. Together, it means a new way to protect and manage joint health. Our platform remotely captures qualitative and quantitative endpoints to provide patients and clinicians with objective levels of disease activity. Synovo does this by using revolutionary AI-driven computer models specifically designed to help manage Rheumatoid Arthritis (RA). Accessible via web and mobile, Synovo acts as a personal RA assistant—empowering patients and clinicians with real-time data for proactive care.
See moreLatest activity
Latest activity from Synovo
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Customers & Market
Careforce
Careforce achieved a 96% renewal rate in the first year at Kern Family Health Care compared to 38% before the AI platform was introduced.
Customers & Market
Vista AI
Vista AI helped Radiology Regional go from 10 cardiac MRI cases/month to 40 cardiac MRI cases/month by leveraging Vista AI
Customers & Market
Dental-X AI
Dental-X AI moved from a front desk verification team to procedure-level validation with six months of verification going from three people to one.
Customers & Market
Red Sky Health
Red Sky Health turned down a client who asked to bypass the internal AI review process to move faster.
Customers & Market
Jorie AI